Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Wiese

Showing results (71-80 of 119) with videos related to

Pageof 12
Sort By:
Computational and Structural Biotechnology Journal|June 18, 2021
Scaffold fragmentation and substructure hopping reveal potential, robustness, and limits of computer-aided pattern analysis (C@PA)Vigneshwaran Namasivayam, Katja Silbermann, Jens Pahnke, et al.
Bioorganic & Medicinal Chemistry Letters|August 19, 2008
A 4-aminobenzoic acid derivative as novel lead for selective inhibitors of multidrug resistance-associated proteinsStefan Leyers, Hans-Georg Häcker, Jeanette Wiendlocha, et al.
Bioorganic & Medicinal Chemistry|March 3, 2009
Synthesis and biological evaluation of a small molecule library of 3rd generation multidrug resistance modulatorsWerner Klinkhammer, Henrik Müller, Christoph Globisch, et al.
International Journal of Clinical Pharmacology and Therapeutics|December 3, 2013
Liposomal cisplatin can overcome chemotherapy resistance of A2780 ovarian cancer cells by inducing the extrinsic apoptotic pathwayDaniel P Stölting, Martin Koch, Michael Wiese, et al.
Cancer Chemotherapy and Pharmacology|April 26, 2006
Novel tetrahydroisoquinolin-ethyl-phenylamine based multidrug resistance inhibitors with broad-spectrum modulating propertiesVeronika Jekerle, Werner Klinkhammer, Raymond M Reilly, et al.
European Journal of Medicinal Chemistry|April 22, 2016
The combination of quinazoline and chalcone moieties leads to novel potent heterodimeric modulators of breast cancer resistance protein (BCRP/ABCG2)Stefanie Kraege, Katja Stefan, Kapil Juvale, et al.
International Journal of Clinical Practice|May 24, 2019
Factors associated with medication adherence in a longitudinal study of rheumatoid arthritis patientsNasir Wabe, Anita Lee, Mihir Wechalekar, et al.
The Journal of Organic Chemistry|January 4, 2011
Total synthesis of natural and non-natural Δ(5,6)Δ(12,13)-jatrophane diterpenes and their evaluation as MDR modulatorsChristoph Schnabel, Katja Sterz, Henrik Müller, et al.
Rheumatology International|February 5, 2017
Adherence to combination DMARD therapy and treatment outcomes in rheumatoid arthritis: a longitudinal study of new and existing DMARD usersNasir Wabe, Anita Lee, Mihir Wechalekar, et al.
Journal of Developmental Origins of Health and Disease|December 22, 2025
Programming fetal cardiometabolic pathways: the double-edged role of glucocorticoids in heart developmentReza Amanollahi, Melanie Bertossa, Kent Thornburg, et al.
Pageof 12

Showing results (71-80 of 119) with videos related to

Sort By:
Pageof 12
Computational and Structural Biotechnology Journal|June 18, 2021
Scaffold fragmentation and substructure hopping reveal potential, robustness, and limits of computer-aided pattern analysis (C@PA)Vigneshwaran Namasivayam, Katja Silbermann, Jens Pahnke, et al.
Bioorganic & Medicinal Chemistry Letters|August 19, 2008
A 4-aminobenzoic acid derivative as novel lead for selective inhibitors of multidrug resistance-associated proteinsStefan Leyers, Hans-Georg Häcker, Jeanette Wiendlocha, et al.
Bioorganic & Medicinal Chemistry|March 3, 2009
Synthesis and biological evaluation of a small molecule library of 3rd generation multidrug resistance modulatorsWerner Klinkhammer, Henrik Müller, Christoph Globisch, et al.
International Journal of Clinical Pharmacology and Therapeutics|December 3, 2013
Liposomal cisplatin can overcome chemotherapy resistance of A2780 ovarian cancer cells by inducing the extrinsic apoptotic pathwayDaniel P Stölting, Martin Koch, Michael Wiese, et al.
Cancer Chemotherapy and Pharmacology|April 26, 2006
Novel tetrahydroisoquinolin-ethyl-phenylamine based multidrug resistance inhibitors with broad-spectrum modulating propertiesVeronika Jekerle, Werner Klinkhammer, Raymond M Reilly, et al.
European Journal of Medicinal Chemistry|April 22, 2016
The combination of quinazoline and chalcone moieties leads to novel potent heterodimeric modulators of breast cancer resistance protein (BCRP/ABCG2)Stefanie Kraege, Katja Stefan, Kapil Juvale, et al.
International Journal of Clinical Practice|May 24, 2019
Factors associated with medication adherence in a longitudinal study of rheumatoid arthritis patientsNasir Wabe, Anita Lee, Mihir Wechalekar, et al.
The Journal of Organic Chemistry|January 4, 2011
Total synthesis of natural and non-natural Δ(5,6)Δ(12,13)-jatrophane diterpenes and their evaluation as MDR modulatorsChristoph Schnabel, Katja Sterz, Henrik Müller, et al.
Rheumatology International|February 5, 2017
Adherence to combination DMARD therapy and treatment outcomes in rheumatoid arthritis: a longitudinal study of new and existing DMARD usersNasir Wabe, Anita Lee, Mihir Wechalekar, et al.
Journal of Developmental Origins of Health and Disease|December 22, 2025
Programming fetal cardiometabolic pathways: the double-edged role of glucocorticoids in heart developmentReza Amanollahi, Melanie Bertossa, Kent Thornburg, et al.
Pageof 12